Safety outcomes
gastrointestinal symptoms, palpitation, skin symptoms
ADVERSE REACTIONS, ADVERSE REACTION, FACIAL EDEMA
No serious adverse reactions were reported. Only 13.33% of patients experienced mild adverse reactions, such as palpitation, skin symptoms, gastrointestinal symptoms, facial edema, and so on. There was no significant difference in adverse reactions between the two groups (13.33% Adverse reaction.